

The COVID-19 pandemic has triggered profound changes in healthcare, with different forces at play influencing the industry. IQVIA explores the implications of these forces, such as increasing public awareness for drug development or changes to traditionally hospital-centric care models on the wider industry; as well as the resulting key investment themes as we continue through the 'new normal' of healthcare.